Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier
Mindset's recent accomplishments have set the stage for its psychedelic drug candidates to be first in human clinical trials by 2023.
Similar Posts
3 Profound Psychedelic Documentaries Streaming Free on YouTube
Watch late psychedelic icons María Sabina and Terence McKenna in action, and catch a glimpse inside psilocybin therapy sessions.
FDA Approves First Clinical Trial Using Naturally Sourced Psychedelics
This trial, using Filament Health’s botanical drug candidates, is the first to assess the direct administration of psilocin.
Microdosing LSD and Psilocybin Rises During Pandemic, Global Drug Survey Finds
The report also explores how microdosing may impact the use of other prescribed mental health medications.
Oregon Announces Creation of the Psilocybin Advisory Board
The first state to legalize therapeutic use of psilocybin, Oregon now has an advisory board to help build its regulations.
Stacking Psychedelic Microdoses with ADHD Medication? New Study Hints “Both And” Could Work
A new study exploring real-world psychedelic microdosing for ADHD could help reimagine the way we perceive and treat the condition.